HMGN3 antisense RNA 1 (HMGN3-AS1)

HMGN3 antisense RNA 1 (HMGN3-AS1) is a long non-coding antisense transcript originating from the HMGN3 gene locus. Antisense RNAs such as HMGN3-AS1 regulate gene expression by forming RNA-RNA duplexes, modifying chromatin accessibility, interfering with transcription, and recruiting chromatin-modifying enzymes and transcription factors[1][3]. The functional effects of antisense RNAs can be classified as cis (local to the locus) or trans (distant), and their mechanisms include modulating transcription initiation/elongation, competing for promoter occupancy, or directly affecting RNA processing and stability[1]. While other HMGN family members (HMGN1, HMGN2, etc.) and their protein products play roles in chromatin structure, DNA repair, and cancer, HMGN3-AS1 itself is not recognized as a disease biomarker, therapeutic target, or direct modulator of clinical outcomes[2]. Its biological roles are inferred from the general properties of antisense lncRNAs, including potential regulation of the paired HMGN3 gene. No established drugs, mechanism-based therapies, or biomarker uses are attributed to HMGN3-AS1. There are no safety concerns documented for this molecule as a therapeutic target. The gene symbol and transcript annotation are confirmed as accurate; there is no evidence of ambiguity or misclassification in current scientific databases.

Other names

HMGN3-AS1